CureVac N.V. (CVAC) last year’s performance of -56.82% is a clear signal for an entertaining trading season.


A new trading day began on Tuesday, with CureVac N.V. (NASDAQ: CVAC) stock price down -3.36% from the previous day of trading, before settling in for the closing price of $2.98. CVAC’s price has ranged from $2.76 to $12.36 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Meanwhile, its annual earnings per share averaged 25.91%. With a float of $91.60 million, this company’s outstanding shares have now reached $223.88 million.

CureVac N.V. (CVAC) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of CureVac N.V. is 59.08%, while institutional ownership is 10.01%.

CureVac N.V. (CVAC) Recent Fiscal highlights

In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.24 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 25.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.76% during the next five years compared to -32.46% drop over the previous five years of trading.

CureVac N.V. (NASDAQ: CVAC) Trading Performance Indicators

Here are CureVac N.V.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.09.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.53, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.99 in one year’s time.

Technical Analysis of CureVac N.V. (CVAC)

Looking closely at CureVac N.V. (NASDAQ: CVAC), its last 5-days average volume was 0.62 million, which is a drop from its year-to-date volume of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 39.33%. Additionally, its Average True Range was 0.18.

During the past 100 days, CureVac N.V.’s (CVAC) raw stochastic average was set at 3.39%, which indicates a significant decrease from 16.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.48% in the past 14 days, which was lower than the 70.91% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.37, while its 200-day Moving Average is $6.20. However, in the short run, CureVac N.V.’s stock first resistance to watch stands at $2.96. Second resistance stands at $3.03. The third major resistance level sits at $3.10. If the price goes on to break the first support level at $2.81, it is likely to go to the next support level at $2.74. Now, if the price goes above the second support level, the third support stands at $2.67.

CureVac N.V. (NASDAQ: CVAC) Key Stats

With a market capitalization of 644.77 million, the company has a total of 223,842K Shares Outstanding. Currently, annual sales are 71,030 K while annual income is -262,380 K. The company’s previous quarter sales were 17,940 K while its latest quarter income was -52,980 K.